Embecta Corp Ownership
| EMBC Stock | USD 10.00 0.06 0.60% |
Shares in Circulation | First Issued 2020-12-31 | Previous Quarter 58.9 M | Current Value 58.9 M | Avarage Shares Outstanding 57.8 M | Quarterly Volatility 650.4 K |
Embecta Stock Ownership Analysis
About 99.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 27th of February 2026. Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people. To learn more about Embecta Corp call Devdatt Kurdikar at 862 401 0000 or check out https://www.embecta.com.Besides selling stocks to institutional investors, Embecta Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Embecta Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Embecta Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Embecta Corp Quarterly Liabilities And Stockholders Equity |
|
Embecta Corp Insider Trades History
Only 1.45% of Embecta Corp are currently held by insiders. Unlike Embecta Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Embecta Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Embecta Corp's insider trades
Embecta Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Embecta Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Embecta Corp backward and forwards among themselves. Embecta Corp's institutional investor refers to the entity that pools money to purchase Embecta Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.2 M | Rubric Capital Management Lp | 2025-06-30 | 1 M | Charles Schwab Investment Management Inc | 2025-06-30 | 886.3 K | Ameriprise Financial Inc | 2025-06-30 | 709.8 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 708.3 K | Northern Trust Corp | 2025-06-30 | 645.1 K | Bank Of New York Mellon Corp | 2025-06-30 | 635.8 K | D. E. Shaw & Co Lp | 2025-06-30 | 618.8 K | Goldman Sachs Group Inc | 2025-06-30 | 471.4 K | Blackrock Inc | 2025-06-30 | 8.9 M | Vanguard Group Inc | 2025-06-30 | 5.5 M |
Embecta Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Embecta Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Embecta Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Embecta Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Embecta Corp's latest congressional trading
Congressional trading in companies like Embecta Corp, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Embecta Corp by those in governmental positions are based on the same information available to the general public.
Embecta Corp Outstanding Bonds
Embecta Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Embecta Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Embecta bonds can be classified according to their maturity, which is the date when Embecta Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| EMERGENT BIOSOLUTIONS INC Corp BondUS29089QAC96 | View | |
| US29082KAA34 Corp BondUS29082KAA34 | View | |
| EMERA INC 675 Corp BondUS290876AD37 | View |
Embecta Corp Corporate Filings
8K | 5th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 30th of January 2026 An amended filing to the original Schedule 13G | ViewVerify |
| 23rd of January 2026 Other Reports | ViewVerify | |
| 18th of December 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Embecta Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Embecta Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Embecta Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Embecta Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Embecta Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Will Health Care Equipment & Supplies sector continue expanding? Could Embecta diversify its offerings? Factors like these will boost the valuation of Embecta Corp. Projected growth potential of Embecta fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Embecta Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.827 | Dividend Share 0.6 | Earnings Share 2.35 | Revenue Per Share | Quarterly Revenue Growth (0) |
Embecta Corp's market price often diverges from its book value, the accounting figure shown on Embecta's balance sheet. Smart investors calculate Embecta Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Embecta Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Embecta Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Embecta Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.